Evolution of the Average Target: Ibnsina Pharma

Evolution of the Target Price: Ibnsina Pharma

Changes in Analyst Recommendations: Ibnsina Pharma

d002807cff258ec9c3489e7a0.-I0tk8nGrFCilWFfSFXBgLwfNwH7lipXKPIIv6Ve6fo.ssFc9aDyziHI8BtrGmeS1tBLdTW94lgHbpBbyNwY2ZzK-HraiKH6HNuhBg~6a1d4f7146aa69445dd2f6c5bfd3931e

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+47.37%
+89.81%
+25.56%
+43.15%
+25.03%
+62.41%
+36.31%
+32.14%
+24.21%
+45.39%
Average +43.14%
Weighted average by Cap. +52.04%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.50EGP
Average target price
17.26EGP
Spread / Average Target
+50.07%
High Price Target
21.00EGP
Spread / Highest target
+82.61%
Low Price Target
14.50EGP
Spread / Lowest Target
+26.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. ISPH Stock
  4. Consensus Ibnsina Pharma